ID: ALA484145

Max Phase: Preclinical

Molecular Formula: C20H16O3

Molecular Weight: 304.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C(=O)/C=C/c2ccc3ccccc3c2)ccc1O

Standard InChI:  InChI=1S/C20H16O3/c1-23-20-13-17(9-11-19(20)22)18(21)10-7-14-6-8-15-4-2-3-5-16(15)12-14/h2-13,22H,1H3/b10-7+

Standard InChI Key:  OAGVNDJNFSRJHP-JXMROGBWSA-N

Associated Targets(Human)

THP-1 11052 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HUVEC 11049 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PBMC 10003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Jurkat 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

REH 364 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 4610 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Probable low molecular weight protein-tyrosine-phosphatase 435 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycobacterium tuberculosis 203094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phosphotyrosine-protein phosphatase PTPB 308 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.35Molecular Weight (Monoisotopic): 304.1099AlogP: 4.45#Rotatable Bonds: 4
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.36CX Basic pKa: CX LogP: 4.42CX LogD: 4.37
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: 0.26

References

1. Navarini AL, Chiaradia LD, Mascarello A, Fritzen M, Nunes RJ, Yunes RA, Creczynski-Pasa TB..  (2009)  Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion.,  44  (4): [PMID:19211173] [10.1016/j.ejmech.2008.09.009]
2. Mascarello A, Chiaradia LD, Vernal J, Villarino A, Guido RV, Perizzolo P, Poirier V, Wong D, Martins PG, Nunes RJ, Yunes RA, Andricopulo AD, Av-Gay Y, Terenzi H..  (2010)  Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth.,  18  (11): [PMID:20462762] [10.1016/j.bmc.2010.04.051]
3. Salum LB, Altei WF, Chiaradia LD, Cordeiro MN, Canevarolo RR, Melo CP, Winter E, Mattei B, Daghestani HN, Santos-Silva MC, Creczynski-Pasa TB, Yunes RA, Yunes JA, Andricopulo AD, Day BW, Nunes RJ, Vogt A..  (2013)  Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.,  63  [PMID:23524161] [10.1016/j.ejmech.2013.02.037]

Source